Metabolites as drivers and targets in rheumatoid arthritis.
Metabolites as drivers and targets in rheumatoid arthritis.
复制标题
代谢物作为类风湿性关节炎的驱动力和靶点。
DOI:
10.1093/cei/uxab021
复制
发表时间:
2022-06-11
影响因子:
4.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by neovascularization, immune cell infiltration, and synovial hyperplasia, which leads to degradation of articular cartilage and bone, and subsequent functional disability. Dysregulated angiogenesis, synovial hypoxia, and immune cell infiltration result in a ‘bioenergetic crisis’ in the inflamed joint which further exacerbates synovial invasiveness. Several studies have examined this vicious cycle between metabolism, immunity, and inflammation and the role metabolites play in these interactions. To add to this complexity, the inflamed synovium is a multicellular tissue with many cellular subsets having different metabolic requirements. Metabolites can shape the inflammatory phenotype of immune cell subsets during disease and act as central signalling hubs. In the RA joint, the increased energy demand of stromal and immune cells leads to the accumulation of metabolites such as lactate, citrate, and succinate as well as adipocytokines which can regulate downstream signalling pathways. Transcription factors such as HIF1ɑ and mTOR can act as metabolic sensors to activate synovial cells and drive pro-inflammatory effector function, thus perpetuating chronic inflammation further. These metabolic intermediates may be potential therapeutic targets and so understanding the complex interplay between metabolites and synovial cells in RA may allow for identification of novel therapeutic strategies but also may provide significant insight into the underlying mechanisms of disease pathogenesis. The adverse microenvironment of the RA inflamed joint forces cells to switch their metabolic pathways in order to sustain their pathogenic activated status. Metabolites act as central hubs influencing multiple cellular functions and signaling pathways that further drive inflammation.
登录
查看更多内容
影响因子:
16.6
作者:
Cruys B;Wong BW;Kuchnio A;Verdegem D;Cantelmo AR;Conradi LC;Vandekeere S;Bouché A;Cornelissen I;Vinckier S;Merks RM;Dejana E;Gerhardt H;Dewerchin M;Bentley K;Carmeliet P
通讯作者:
Carmeliet P
影响因子:
--
作者:
Evans, Laura;Williams, Anwen S.;Nowell, Mari
通讯作者:
Nowell, Mari
影响因子:
64.8
作者:
Bambouskova M;Gorvel L;Lampropoulou V;Sergushichev A;Loginicheva E;Johnson K;Korenfeld D;Mathyer ME;Kim H;Huang LH;Duncan D;Bregman H;Keskin A;Santeford A;Apte RS;Sehgal R;Johnson B;Amarasinghe GK;Soares MP;Satoh T;Akira S;Hai T;de Guzman Strong C;Auclair K;Roddy TP;Biller SA;Jovanovic M;Klechevsky E;Stewart KM;Randolph GJ;Artyomov MN
通讯作者:
Artyomov MN
影响因子:
29
作者:
Angelin A;Gil-de-Gómez L;Dahiya S;Jiao J;Guo L;Levine MH;Wang Z;Quinn WJ 3rd;Kopinski PK;Wang L;Akimova T;Liu Y;Bhatti TR;Han R;Laskin BL;Baur JA;Blair IA;Wallace DC;Hancock WW;Beier UH
通讯作者:
Beier UH
影响因子:
4.8
作者:
Dai, Qiaoding;Zhou, Di;Song, Xinwei
通讯作者:
Song, Xinwei